Insiders · Profile

MORROW GEORGE J

Director at NEUROCRINE BIOSCIENCES · Director at Align Technology · Exe VP, Global Commercial Ops at Amgen. Filing since 26 Oct 2000. CIK 0001068754

Company
Date
Role
Action
Shares
Amount
Of holding
25 Nov 2025
Director
Sold on a plan
15,000
$2.15M
68.0%
14 Mar 2024
Director
Sold on a plan
40,000
$5.58M
100%
2 Aug 2021
Director
Sold, plan not stated
5,000
$3.54M
28.2%
8 Feb 2021
Director
Sold, plan not stated
15,000
$9.37M
47.7%
4 Nov 2020
Director
Sold, plan not stated
5,000
$2.40M
13.7%
26 Oct 2020
Director
Sold, plan not stated
17,273
$8.04M
30.6%
23 May 2016
Director
Sold, plan not stated
50,000
$3.89M
51.9%
22 Oct 2013
Director
Sold, plan not stated
75,000
$4.30M
73.0%
9 Jun 2009
Exe VP, Global Commercial Ops
Sold, plan not stated
21,000
$1.07M
18.3%
24 Oct 2008
Exe VP, Global Commercial Ops
Sold, plan not stated
57,394
$3.13M
38.0%
15 May 2008
Director
Bought
5,000
$63.14K
167%
7 Dec 2007
Exe VP, Global Commercial Ops
Bought
2,025
$141.72K
opened
26 Oct 2000
Director
Sold, plan not stated
2,727
$1.28M
7.0%
13 decisions on file.